Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|March 25, 2022
Increasing Role of Targeted Immunotherapies in the Treatment of AMLJochen Greiner, Marlies Götz, Verena WaisClinical & Developmental Immunology|May 22, 2012
Immunogenic targets for specific immunotherapy in multiple myelomaLu Zhang, Marlies Götz, Susanne Hofmann, et al.Journal of Clinical Medicine|December 28, 2019
Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML PatientsJochen Greiner, Marlies Götz, Donald Bunjes, et al.Leukemia & Lymphoma|October 30, 2012
Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemiaVanessa Schneider, Stephanie Egenrieder, Marlies Götz, et al.Oncology Reports|October 25, 2013
Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapyAnna Babiak, Max Steinhauser, Marlies Götz, et al.International Journal of Cancer|July 15, 2018
Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical respondersSusanne Hofmann, Michael Schmitt, Marlies Götz, et al.Cancer Immunology, Immunotherapy : CII|February 6, 2020
Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibitionJochen Greiner, Marlies Götz, Susanne Hofmann, et al.Cancers|October 26, 2024
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid LeukemiaJochen Greiner, Eithar Mohamed, Daniel M Fletcher, et al.International Journal of Molecular Sciences|June 10, 2023
A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia CellsBarbara-Ann Guinn, Patrick J Schuler, Hubert Schrezenmeier, et al.Molecular Cancer|February 2, 2010
Effects of nilotinib on regulatory T cells: the dose mattersFei Fei, Yingzhe Yu, Anita Schmitt, et al.Pageof 3